Lessons from Reverse Vaccinology for viral vaccine design

Current Opinion in Virology

Volumn 11, Issue , 2015, Pages 89-97

  Bruno, Luca ^a   Cortese, Mirko ^b   Rappuoli, Rino ^a   Merola, Marcello ^a,c  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE; HERPES VACCINE;

ARTICLE; BIOINFORMATICS; DRUG DESIGN; HERPESVIRIDAE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; SYNTHETIC BIOLOGY; VACCINATION; VIRUS MORPHOLOGY; DRUG DEVELOPMENT; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES; REVERSE GENETICS;

DRUG DISCOVERY; HERPESVIRIDAE; HERPESVIRUS VACCINES; HUMANS; REVERSE GENETICS;

EID: 84925841866     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.03.001     Document Type: Review

References (82)

1. S. Riedel Edward Jenner and the history of smallpox and vaccination Proc Bayl Univ Med Cent 18 2005 21 25
2. I. Delany, R. Rappuoli, and E. De Gregorio Vaccines for the 21st century EMBO Mol Med 6 2014 708 720
3. A. Schubert-Unkmeir, and M. Christodoulides Genome-based bacterial vaccines: current state and future outlook BioDrugs Clin Immunother Biopharm Gene Ther 27 2013 419 430
4. R.D. Fleischmann, M.D. Adams, O. White, R.A. Clayton, E.F. Kirkness, A.R. Kerlavage, C.J. Bult, J.F. Tomb, B.A. Dougherty, and J.M. Merrick Whole-genome random sequencing and assembly of Haemophilus influenzae Rd Science 269 1995 496 512
5. M. Pizza, V. Scarlato, V. Masignani, M.M. Giuliani, B. Aricò, M. Comanducci, G.T. Jennings, L. Baldi, E. Bartolini, and B. Capecchi Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing Science 287 2000 1816 1820
6. H. Tettelin, N.J. Saunders, J. Heidelberg, A.C. Jeffries, K.E. Nelson, J.A. Eisen, K.A. Ketchum, D.W. Hood, J.F. Peden, and R.J. Dodson Complete genome sequence of Neisseria meningitidis serogroup B strain MC58 Science 287 2000 1809 1815
7. O. Finco, and R. Rappuoli Designing vaccines for the twenty-first century society Front Immunol 5 2014 12
8. M.M. Giuliani, J. Adu-Bobie, M. Comanducci, B. Aricò, S. Savino, L. Santini, B. Brunelli, S. Bambini, A. Biolchi, and B. Capecchi A universal vaccine for serogroup B meningococcus Proc Natl Acad Sci U S A 103 2006 10834 10839
9. S. Esposito, L. Castellazzi, A. Bosco, A. Musio, and J. Stoddard Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention Immunotherapy 6 2014 395 408
10. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359 362
11. Q.L. Choo, K.H. Richman, J.H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, R. Medina-Selby, and P.J. Barr Genetic organization and diversity of the hepatitis C virus Proc Natl Acad Sci U S A 88 1991 2451 2455
12. Q.L. Choo, G. Kuo, R. Ralston, A. Weiner, D. Chien, G. Van Nest, J. Han, K. Berger, K. Thudium, and C. Kuo Vaccination of chimpanzees against infection by the hepatitis C virus Proc Natl Acad Sci U S A 91 1994 1294 1298
13. B.D. Lindenbach, M.J. Evans, A.J. Syder, B. Wölk, T.L. Tellinghuisen, C.C. Liu, T. Maruyama, R.O. Hynes, D.R. Burton, and J.A. McKeating Complete replication of hepatitis C virus in cell culture Science 309 2005 623 626
14. T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H.-G. Kräusslich, and M. Mizokami Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat Med 11 2005 791 796
15. H. Tettelin, V. Masignani, M.J. Cieslewicz, C. Donati, D. Medini, N.L. Ward, S.V. Angiuoli, J. Crabtree, A.L. Jones, and A.S. Durkin Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome" Proc Natl Acad Sci U S A 102 2005 13950 13955
16. H. Tettelin The bacterial pan-genome and reverse vaccinology Genome Dyn 6 2009 35 47
17. D. Maione, I. Margarit, C.D. Rinaudo, V. Masignani, M. Mora, M. Scarselli, H. Tettelin, C. Brettoni, E.T. Iacobini, and R. Rosini Identification of a universal Group B streptococcus vaccine by multiple genome screen Science 309 2005 148 150
18. A.P. Durbin, and S.S. Whitehead Next-generation dengue vaccines: novel strategies currently under development Viruses 3 2011 1800 1814
19. Y.H. Grad, R. Newman, M. Zody, X. Yang, R. Murphy, J. Qu, C.M. Malboeuf, J.Z. Levin, M. Lipsitch, and J. DeVincenzo Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure J Virol 88 2014 7286 7293
20. S.B. Chabria, S. Gupta, and M.J. Kozal Deep sequencing of HIV: clinical and research applications Annu Rev Genomics Hum Genet 15 2014 295 325
21. A.M. Khan, A.T. Heiny, K.X. Lee, K.N. Srinivasan, T.W. Tan, J.T. August, and V. Brusic Large-scale analysis of antigenic diversity of T-cell epitopes in dengue virus BMC Bioinform 7 Suppl. 5 2006 S4
22. N. Stern-Ginossar, B. Weisburd, A. Michalski, V.T.K. Le, M.Y. Hein, S.-X. Huang, M. Ma, B. Shen, S.-B. Qian, and H. Hengel Decoding human cytomegalovirus Science 338 2012 1088 1093
23. E. Van Damme, and M. Van Loock Functional annotation of human cytomegalovirus gene products: an update Front Microbiol 5 2014 218
24. N. Renzette, L. Gibson, J.D. Jensen, and T.F. Kowalik Human cytomegalovirus intrahost evolution - a new avenue for understanding and controlling herpesvirus infections Curr Opin Virol 8 2014 109 115
25. J.S. McLellan, M. Chen, M.G. Joyce, M. Sastry, G.B.E. Stewart-Jones, Y. Yang, B. Zhang, L. Chen, S. Srivatsan, and A. Zheng Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus Science 342 2013 592 598
26. C.M. Romano, M. Lauck, F.S. Salvador, C.R. Lima, L.S. Villas-Boas, E.S.A. Araújo, J.E. Levi, C.S. Pannuti, D. O'Connor, and E.G. Kallas Inter- and intra-host viral diversity in a large seasonal DENV2 outbreak PLoS One 8 2013 e70318
27. P. Parameswaran, P. Charlebois, Y. Tellez, A. Nunez, E.M. Ryan, C.M. Malboeuf, J.Z. Levin, N.J. Lennon, A. Balmaseda, and E. Harris Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity J Virol 86 2012 8546 8558
28. Y. He, R. Rappuoli, A.S. De Groot, and R.T. Chen Emerging vaccine informatics J Biomed Biotechnol 2010 2010 218590
29. Y. He, R. Racz, S. Sayers, Y. Lin, T. Todd, J. Hur, X. Li, M. Patel, B. Zhao, and M. Chung Updates on the web-based VIOLIN vaccine database and analysis system Nucleic Acids Res 42 2014 D1124 D1132
30. Y. He, and Z. Xiang Databases and in silico tools for vaccine design Methods Mol Biol 993 2013 115 127
31. U. Kulkarni-Kale, S. Bhosle, G.S. Manjari, and A.S. Kolaskar VirGen: a comprehensive viral genome resource Nucleic Acids Res 32 2004 D289 D292
32. U. Kulkarni-Kale, S.G. Bhosle, G.S. Manjari, M. Joshi, S. Bansode, and A.S. Kolaskar Curation of viral genomes: challenges, applications and the way forward BMC Bioinform 7 Suppl. 5 2006 S12
33. Y. He, Z. Xiang, and H.L.T. Mobley Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development J Biomed Biotechnol 2010 2010 297505
34. Z. Xiang, and Y. He Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology BMC Bioinform 14 Suppl. 4 2013 S2
35. A.S. De Groot, B.M. Jesdale, E. Szu, J.R. Schafer, R.M. Chicz, and G. Deocampo An interactive Web site providing major histocompatibility ligand predictions: application to HIV research AIDS Res Hum Retroviruses 13 1997 529 531
36. L. Moise, J.A. McMurry, S. Buus, S. Frey, W.D. Martin, and A.S. De Groot In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes Vaccine 27 2009 6471 6479
37. L. Moise, R.M. Buller, J. Schriewer, J. Lee, S.E. Frey, D.B. Weiner, W. Martin, and A.S. De Groot VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone Vaccine 29 2011 501 511
38. B. Roizman, and R.J. Whitley An inquiry into the molecular basis of HSV latency and reactivation Annu Rev Microbiol 67 2013 355 374
39. S. Awasthi, and H.M. Friedman Status of prophylactic and therapeutic genital herpes vaccines Curr Opin Virol 6 2014 6 12
40. A. Dolan, C. Cunningham, R.D. Hector, A.F. Hassan-Walker, L. Lee, C. Addison, D.J. Dargan, D.J. McGeoch, D. Gatherer, and V.C. Emery Genetic content of wild-type human cytomegalovirus J Gen Virol 85 2004 1301 1312
41. C. Sinzger, M. Digel, and G. Jahn Cytomegalovirus cell tropism Curr Top Microbiol Immunol 325 2008 63 83
42. A.L. Vanarsdall, and D.C. Johnson Human cytomegalovirus entry into cells Curr Opin Virol 2 2012 37 42
43. J. Hassan, and J. Connell Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on Clin Exp Immunol 149 2007 205 210
44. S.P. Adler, S.E. Starr, S.A. Plotkin, S.H. Hempfling, J. Buis, M.L. Manning, and A.M. Best Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age J Infect Dis 171 1995 26 32
45. K.B. Fowler, S. Stagno, and R.F. Pass Maternal immunity and prevention of congenital cytomegalovirus infection JAMA 289 2003 1008 1011
46. M.G. Revello, C. Fornara, A. Arossa, P. Zelini, and D. Lilleri Role of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women Early Hum Dev 90 Suppl. 1 2014 S32 S34
47. W.J. Britt, L. Vugler, E.J. Butfiloski, and E.B. Stephens Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response J Virol 64 1990 1079 1085
48. M. Mach, B. Kropff, P. Dal Monte, and W. Britt Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73) J Virol 74 2000 11881 11892
49. M. Urban, M. Klein, W.J. Britt, E. Hassfurther, and M. Mach Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response J Gen Virol 77 Pt 7 1996 1537 1547
50. L. Rasmussen, C. Matkin, R. Spaete, C. Pachl, and T.C. Merigan Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans J Infect Dis 164 1991 835 842
51. A.E. Fouts, P. Chan, J.-P. Stephan, R. Vandlen, and B. Feierbach Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin J Virol 86 2012 7444 7447
52. D. Lilleri, A. Kabanova, M.G. Revello, E. Percivalle, A. Sarasini, E. Genini, F. Sallusto, A. Lanzavecchia, D. Corti, and G. Gerna Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection PLoS One 8 2013 e59863
53. D. Lilleri, A. Kabanova, A. Lanzavecchia, and G. Gerna Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo J Clin Immunol 32 2012 1324 1331
54. Y. Weisblum, A. Panet, R. Haimov-Kochman, and D.G. Wolf Models of vertical cytomegalovirus (CMV) transmission and pathogenesis Semin Immunopathol 36 2014 615 625
55. J.D. Deere, and P.A. Barry Using the nonhuman primate model of HCMV to guide vaccine development Viruses 6 2014 1483 1501
56. A. Macagno, N.L. Bernasconi, F. Vanzetta, E. Dander, A. Sarasini, M.G. Revello, G. Gerna, F. Sallusto, and A. Lanzavecchia Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex J Virol 84 2010 1005 1013
57. J.F. Kaye, U.A. Gompels, and A.C. Minson Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product J Gen Virol 73 Pt 10 1992 2693 2698
58. B.J. Ryckman, M.C. Chase, and D.C. Johnson Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions J Virol 84 2010 2597 2609
59. M. Zhou, Q. Yu, A. Wechsler, and B.J. Ryckman Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope J Virol 87 2013 9680 9690
60. D.C. Freed, Q. Tang, A. Tang, F. Li, X. He, Z. Huang, W. Meng, L. Xia, A.C. Finnefrock, and E. Durr Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine Proc Natl Acad Sci U S A 110 2013 E4997 E5005
61. N.T. Ingolia Ribosome profiling: new views of translation, from single codons to genome scale Nat Rev Genet 15 2014 205 213
62. N.T. Ingolia, G.A. Brar, N. Stern-Ginossar, M.S. Harris, G.J.S. Talhouarne, S.E. Jackson, M.R. Wills, and J.S. Weissman Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes Cell Rep 8 2014 1365 1379
63. M.H.V. Van Regenmortel Limitations to the structure-based design of HIV-1 vaccine immunogens J Mol Recognit 24 2011 741 753
64. L. Kong, and Q.J. Sattentau Antigenicity and immunogenicity in HIV-1 antibody-based vaccine design J AIDS Clin Res Suppl 8 2012 3
65. M.P. Weekes, P. Tomasec, E.L. Huttlin, C.A. Fielding, D. Nusinow, R.J. Stanton, E.C.Y. Wang, R. Aicheler, I. Murrell, and G.W.G. Wilkinson Quantitative temporal viromics: an approach to investigate host-pathogen interaction Cell 157 2014 1460 1472
66. M. Scarselli, B. Aricò, B. Brunelli, S. Savino, F. Di Marcello, E. Palumbo, D. Veggi, L. Ciucchi, E. Cartocci, and M.J. Bottomley Rational design of a meningococcal antigen inducing broad protective immunity Sci Transl Med 3 2011 91ra62
67. H. Nair, D.J. Nokes, B.D. Gessner, M. Dherani, S.A. Madhi, R.J. Singleton, K.L. O'Brien, A. Roca, P.F. Wright, and N. Bruce Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis Lancet 375 2010 1545 1555
68. A.Z. Kapikian, R.H. Mitchell, R.M. Chanock, R.A. Shvedoff, and C.E. Stewart An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine Am J Epidemiol 89 1969 405 421
69. H.W. Kim, J.G. Canchola, C.D. Brandt, G. Pyles, R.M. Chanock, K. Jensen, and R.H. Parrott Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine Am J Epidemiol 89 1969 422 434
70. J.S. McLellan, M. Chen, S. Leung, K.W. Graepel, X. Du, Y. Yang, T. Zhou, U. Baxa, E. Yasuda, and T. Beaumont Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody Science 340 2013 1113 1117
71. J.S. McLellan, Y. Yang, B.S. Graham, and P.D. Kwong Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes J Virol 85 2011 7788 7796
72. K.A. Swanson, E.C. Settembre, C.A. Shaw, A.K. Dey, R. Rappuoli, C.W. Mandl, P.R. Dormitzer, and A. Carfi Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers Proc Natl Acad Sci U S A 108 2011 9619 9624
73. M. Magro, V. Mas, K. Chappell, M. Vázquez, O. Cano, D. Luque, M.C. Terrón, J.A. Melero, and C. Palomo Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention Proc Natl Acad Sci U S A 109 2012 3089 3094
74. P.D. Kwong, and J.R. Mascola Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies Immunity 37 2012 412 425
75. D.C. Ekiert, and I.A. Wilson Broadly neutralizing antibodies against influenza virus and prospects for universal therapies Curr Opin Virol 2 2012 134 141
76. D.C. Ekiert, G. Bhabha, M.-A. Elsliger, R.H.E. Friesen, M. Jongeneelen, M. Throsby, J. Goudsmit, and I.A. Wilson Antibody recognition of a highly conserved influenza virus epitope Science 324 2009 246 251
77. T. Zhou, I. Georgiev, X. Wu, Z.-Y. Yang, K. Dai, A. Finzi, Y.D. Kwon, J.F. Scheid, W. Shi, and L. Xu Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 Science 329 2010 811 817
78. J. Jardine, J.-P. Julien, S. Menis, T. Ota, O. Kalyuzhniy, A. McGuire, D. Sok, P.-S. Huang, S. MacPherson, and M. Jones Rational HIV immunogen design to target specific germline B cell receptors Science 340 2013 711 716
79. S. Rerks-Ngarm, P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu, R. Paris, N. Premsri, C. Namwat, M. de Souza, and E. Adams Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand N Engl J Med 361 2009 2209 2220
80. D.G. Gibson, G.A. Benders, C. Andrews-Pfannkoch, E.A. Denisova, H. Baden-Tillson, J. Zaveri, T.B. Stockwell, A. Brownley, D.W. Thomas, and M.A. Algire Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome Science 319 2008 1215 1220
81. P.R. Dormitzer, P. Suphaphiphat, D.G. Gibson, D.E. Wentworth, T.B. Stockwell, M.A. Algire, N. Alperovich, M. Barro, D.M. Brown, and S. Craig Synthetic generation of influenza vaccine viruses for rapid response to pandemics Sci Transl Med 5 2013 185ra68
82. S.A. Bart, M. Hohenboken, G. Della Cioppa, V. Narasimhan, P.R. Dormitzer, and N. Kanesa-Thasan A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults Sci Transl Med 6 2014 234ra55